BTK and B-cell chronic lymphocytic leukemia: Bruton tyrosin kinase inhibitors (BTKIs) are being widely used as an efficacious therapy for patients with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL).